Search

Shengjun Wang

Examiner (ID: 13636, Phone: (571)272-0632 , Office: P/1627 )

Most Active Art Unit
1627
Art Unit(s)
1617, 1627
Total Applications
2559
Issued Applications
1079
Pending Applications
238
Abandoned Applications
1248

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12247283 [patent_doc_number] => 09920049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-20 [patent_title] => 'Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection' [patent_app_type] => utility [patent_app_number] => 15/349343 [patent_app_country] => US [patent_app_date] => 2016-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25120 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349343 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/349343
Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection Nov 10, 2016 Issued
Array ( [id] => 11618233 [patent_doc_number] => 20170128421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'Premix formulation for parenteral use and packaging thereof' [patent_app_type] => utility [patent_app_number] => 15/348374 [patent_app_country] => US [patent_app_date] => 2016-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6189 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15348374 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/348374
Premix formulation for parenteral use and packaging thereof Nov 9, 2016 Abandoned
Array ( [id] => 16244789 [patent_doc_number] => 10744113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-18 [patent_title] => Use of chromone derivative as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity [patent_app_type] => utility [patent_app_number] => 15/347795 [patent_app_country] => US [patent_app_date] => 2016-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9293 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347795 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/347795
Use of chromone derivative as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity Nov 9, 2016 Issued
Array ( [id] => 13504545 [patent_doc_number] => 20180303815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-25 [patent_title] => COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 15/767914 [patent_app_country] => US [patent_app_date] => 2016-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16412 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767914 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/767914
Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer Nov 2, 2016 Issued
Array ( [id] => 11441848 [patent_doc_number] => 20170042869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'Methods for limiting acute kidney injury' [patent_app_type] => utility [patent_app_number] => 15/334770 [patent_app_country] => US [patent_app_date] => 2016-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5304 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15334770 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/334770
Methods for limiting acute kidney injury Oct 25, 2016 Abandoned
Array ( [id] => 11554161 [patent_doc_number] => 20170100400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-13 [patent_title] => 'INHIBITORS OF INFLUENZA VIRUSES REPLICATION' [patent_app_type] => utility [patent_app_number] => 15/299757 [patent_app_country] => US [patent_app_date] => 2016-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 115 [patent_figures_cnt] => 115 [patent_no_of_words] => 207834 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299757 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/299757
Inhibitors of influenza viruses replication Oct 20, 2016 Issued
Array ( [id] => 11441878 [patent_doc_number] => 20170042900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'PREVENTIVE AND/OR THERAPEUTIC AGENT OF IMMUNE DISEASE' [patent_app_type] => utility [patent_app_number] => 15/297196 [patent_app_country] => US [patent_app_date] => 2016-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 42910 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15297196 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/297196
Preventive and/or therapeutic agent of immune disease Oct 18, 2016 Issued
Array ( [id] => 11401692 [patent_doc_number] => 20170022227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'CRYSTALLIZATION METHOD AND BIOAVAILABILITY' [patent_app_type] => utility [patent_app_number] => 15/288139 [patent_app_country] => US [patent_app_date] => 2016-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 70944 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288139 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/288139
Crystallization method and bioavailability Oct 6, 2016 Issued
15/283422 5-SUBSTITUTED 2, 4-THIAZOLIDINEDIONES (THIOHYDANTOINS), PSEUDOTHIOHYDANTOINS, AND PROPSEUDOTHIOHYDANTOINS FOR USE AS ANTIVIRAL AND ANTIFUNGAL AGENTS Oct 1, 2016 Abandoned
Array ( [id] => 11381482 [patent_doc_number] => 20170007538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'INJECTION PREPARATION AND METHOD FOR PRODUCING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/269989 [patent_app_country] => US [patent_app_date] => 2016-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14093 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15269989 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/269989
Injection preparation and method for producing the same Sep 19, 2016 Issued
Array ( [id] => 13674995 [patent_doc_number] => 20160376231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => ANTIVIRAL COMPOUNDS AND METHODS [patent_app_type] => utility [patent_app_number] => 15/262075 [patent_app_country] => US [patent_app_date] => 2016-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7867 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15262075 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/262075
Antiviral compounds and methods Sep 11, 2016 Issued
Array ( [id] => 13635179 [patent_doc_number] => 09844539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-19 [patent_title] => Compounds and methods for kinase modulation, and indications therefor [patent_app_type] => utility [patent_app_number] => 15/260042 [patent_app_country] => US [patent_app_date] => 2016-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35631 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15260042 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/260042
Compounds and methods for kinase modulation, and indications therefor Sep 7, 2016 Issued
Array ( [id] => 12171011 [patent_doc_number] => 09889127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-13 [patent_title] => 'Method of inhibiting mutant C-KIT' [patent_app_type] => utility [patent_app_number] => 15/255912 [patent_app_country] => US [patent_app_date] => 2016-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5555 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15255912 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/255912
Method of inhibiting mutant C-KIT Sep 1, 2016 Issued
Array ( [id] => 11455849 [patent_doc_number] => 20170049751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-23 [patent_title] => 'OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/254271 [patent_app_country] => US [patent_app_date] => 2016-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31199 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15254271 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/254271
OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF Aug 31, 2016 Abandoned
Array ( [id] => 13383813 [patent_doc_number] => 20180243448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => DEVICES, KITS, AND METHODS FOR DETERMINING INEFFECTIVENESS OF ANESTHETICS [patent_app_type] => utility [patent_app_number] => 15/755127 [patent_app_country] => US [patent_app_date] => 2016-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5187 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -69 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755127 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/755127
DEVICES, KITS, AND METHODS FOR DETERMINING INEFFECTIVENESS OF ANESTHETICS Aug 25, 2016 Abandoned
Array ( [id] => 11362791 [patent_doc_number] => 20170000772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'SMALL MOLECULE MODULATORS OF PRB INACTIVATION' [patent_app_type] => utility [patent_app_number] => 15/237801 [patent_app_country] => US [patent_app_date] => 2016-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14081 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15237801 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/237801
SMALL MOLECULE MODULATORS OF PRB INACTIVATION Aug 15, 2016 Abandoned
Array ( [id] => 13672467 [patent_doc_number] => 20160374967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 15/235847 [patent_app_country] => US [patent_app_date] => 2016-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14105 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15235847 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/235847
ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS Aug 11, 2016 Abandoned
Array ( [id] => 11421214 [patent_doc_number] => 20170029359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'ANTIMICROBIAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 15/234592 [patent_app_country] => US [patent_app_date] => 2016-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15662 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15234592 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/234592
ANTIMICROBIAL COMPOUNDS Aug 10, 2016 Abandoned
Array ( [id] => 13165555 [patent_doc_number] => 10098869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-16 [patent_title] => Compounds for the treatment of cancers associated with human papillomavirus [patent_app_type] => utility [patent_app_number] => 15/231684 [patent_app_country] => US [patent_app_date] => 2016-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8919 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15231684 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/231684
Compounds for the treatment of cancers associated with human papillomavirus Aug 7, 2016 Issued
Array ( [id] => 15571449 [patent_doc_number] => 10576083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-03 [patent_title] => Method of treating pulmonary arterial hypertension [patent_app_type] => utility [patent_app_number] => 15/230803 [patent_app_country] => US [patent_app_date] => 2016-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3748 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15230803 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/230803
Method of treating pulmonary arterial hypertension Aug 7, 2016 Issued
Menu